Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).
Saverio Cinieri
Other Remuneration - Bayer
Arlene Chan
No relevant relationships to disclose
Kadri Altundag
No relevant relationships to disclose
Ann Vandebroek
No relevant relationships to disclose
Nicole Tubiana-Mathieu
No relevant relationships to disclose
Agusti Barnadas
No relevant relationships to disclose
Patricia Dodyk
No relevant relationships to disclose
Silvia Lazzarelli
No relevant relationships to disclose
Michiel Botha
No relevant relationships to disclose
Daniel Rauch
No relevant relationships to disclose
Rustem Khasanov
No relevant relationships to disclose
Coenraad Frederik Slabber
No relevant relationships to disclose
Philippe Bougnoux
No relevant relationships to disclose
Jesus S. Cardenas
No relevant relationships to disclose
Javier Castellanos Diez
No relevant relationships to disclose
Marcus Schmidt
No relevant relationships to disclose
Maria Jose Godes
No relevant relationships to disclose
Dar-Ren Chen
No relevant relationships to disclose
Gustavo Villanova
Employment or Leadership Position - Pierre Fabre Medicament
Ugur Coskun
No relevant relationships to disclose